Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Eros Capital Partners AB | 144,244 | net | 28 Jan 2026 | tx 3+144,244 |
| Inify Laboratories AB | 105,363 | net | 18 Dec 2025 | tx 2+105,363 |
| ContextVision AB | 12,000 | net | 21 Oct 2021 | tx 4+12,000 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 28 Jan 2026 | PURCHASE | Eros Capital Partners AB | 67,372 | 3.50 NOK | |
| 18 Dec 2025 | PURCHASE | Inify Laboratories AB | 30,000 | 3.30 NOK | |
| 28 Aug 2025 | PURCHASE | Eros Capital Partners AB | 9,500 | 5.50 NOK | |
| 23 Jan 2025 | PURCHASE | Inify Laboratories AB | 75,363 | 4.50 NOK | first after silence |
| 21 Oct 2021 | PURCHASE | ContextVision AB | 6,000 | 22.10 NOK | |
| 01 Sept 2021 | PURCHASE | ContextVision AB | 4,759 | 24.40 NOK | |
| 01 Sept 2021 | PURCHASE | ContextVision AB | 402 | 24.40 NOK | |
| 01 Sept 2021 | PURCHASE | ContextVision AB | 839 | 24.50 NOK |
1 purchase reported after at least 12 months of silence — most recent on 23 Jan 2025.